ArticleJournal of biomedical materials research. Part B, Applied biomaterials2021
Crystalline phase evolution and thermal behavior of zirconia-lanthanum aluminate ceramics produced by surface modification.
Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The purpose of the present work was to investigate the effect doping with lanthanum aluminate on the phase assemblage and thermal behavior of zirconia ceramics for biomedical applications. Four compositions were prepared by a surface modification route of either conventional tetragonal zirconia (3Y-TZP) or high translucency cubic-based zirconia (5Y-PSZ) to reach a nominal composition of either 0.5 wt. % (3Y-0.5LAO and 5Y-0.5LAO) or 5 wt. % of lanthanum monoaluminate (3Y-5LAO and 5Y-5LAO). Undoped powders were used as controls. DTA and XRD analyses revealed that lanthanum dizirconate crystallized in the 934°C-936°C range, while lanthanum aluminate crystallized in the 1,056°C-1,063°C range in both types of zirconias doped at the 5% level. No second phase was found in compositions doped at the 0.5% level. The a lattice parameter and the amount of the cubic phase increased in both 3Y-5LAO and 5Y-5LAO. The microstructure of the compositions doped with 5% LAO was characterized by well distributed LAO twinned crystals and sparse needle-shaped lanthanum hexaaluminate crystals. A bimodal grain size distribution was observed in 5Y-doped compositions. This was attributed to abnormal grain growth of the cubic phase, and in line with aluminum segregation at grain boundaries and the presence of second-phase LAO crystals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.